Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

December 1, 2024

Conditions

Type 2 Diabetes

Interventions

DRUG

Vildagliptin 50 MG

vildagliptin plus their metformin.

DRUG

Glimepiride 3 Mg Oral Tablet

glimepiride plus their metformin

Trial Locations (1)

Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes., Damanhūr

All Listed Sponsors

lead

Damanhour University

OTHER